Campbell & Co Investment Adviser’s Teladoc Health TDOC Stock Holding History

Campbell & Co Investment Adviser’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-11,378	Closed	-$88K	–	1396
2025 Q3	$88K	Buy	+11,378	New	+$88.8K	0.01%	1047
2024 Q3	–	Sell	-71,527	Closed	-$700K	–	1325
2024 Q2	$700K	Buy	71,527 +53,748	+302%	+$656K	0.06%	516
2024 Q1	$268K	Buy	17,779 +1,105	+7%	+$20.1K	0.02%	945
2023 Q4	$359K	Buy	+16,674	New	+$308K	0.03%	854
2023 Q3	–	Sell	-21,329	Closed	-$540K	–	1187
2023 Q2	$540K	Buy	+21,329	New	+$537K	0.1%	395
2022 Q3	–	Sell	-8,882	Closed	-$295K	–	931
2022 Q2	$295K	Buy	+8,882	New	+$377K	0.08%	469
2020 Q3	–	Sell	-1,370	Closed	-$261K	–	475
2020 Q2	$261K	Buy	+1,370	New	+$240K	0.33%	128

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Campbell & Co Investment Adviser's TDOC Position: Q4 2025 in Review

Campbell & Co Investment Adviser sold out of Teladoc Health (TDOC) in Q4 2025, closing a stake of 11,378 shares — an estimated $88K sold.

Campbell & Co Investment Adviser first reported a position in TDOC in Q2 2020 and held it in 7 quarters. The position peaked at $700K in Q2 2024. 344 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

Campbell & Co Investment Adviser reported no remaining Teladoc Health position as of Q4 2025 after selling out during the quarter.
Campbell & Co Investment Adviser sold 11,378 Teladoc Health shares in Q4 2025, an estimated $88K.
Campbell & Co Investment Adviser first reported a position in Teladoc Health in Q2 2020 and held it in 7 quarters.
Campbell & Co Investment Adviser's Teladoc Health position peaked at $700K in Q2 2024.
344 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2025, filed 12 Feb 2026.